A Business at a Glance
0 of 5 daily views used (5 remaining). Sign up free for 10 daily views, or try AAPL for a full preview.
We are a wearable medical robotics company that offers functional improvement for those with neuromuscular disorders and upper limb paralysis. We develop and market the MyoPro product line. A MyoPro is a myoelectric-controlled upper limb brace, or orthosis. The orthosis is a rigid brace used for the purpose of supporting a patient’s weak or paralyzed arm to enable and help improve functional activities of daily living, or ADLs, in the home and community. It is custom-fabricated by trained professionals during a custom fabrication process for each individual user to meet their specific needs. Our products are designed to help improve function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury and other neurological disorders. We primarily provide devices directly to patients and bill their insurance companies directly, a sales channel we refer to as direct billing.
| Metric | TTM | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue | 42M | 33M | 19M | 16M | 14M | 7.6M |
| Net Income | -12M | -6.2M | -8.1M | -11M | -11M | -12M |
| EPS | $-0.28 | $-0.16 | $-0.28 | $-1.52 | $-1.89 | $-3.67 |
| Free Cash Flow | -14M | -4.7M | -6.3M | -10M | -9.9M | -9.1M |
| ROIC | -165.9% | -25.0% | -90.6% | -132.6% | -71.5% | -98.2% |
| Gross Margin | 66.6% | 71.2% | 68.5% | 65.9% | 74.4% | 65.7% |
| Debt/Equity | 0.25 | 0.02 | 0.62 | 0.60 | 0.30 | 0.23 |
| Dividends/Share | $0.00 | - | - | - | - | - |
| Operating Income | -12M | -6.2M | -8.2M | -11M | -10M | -11M |
| Operating Margin | -28.5% | -19.1% | -42.8% | -68.6% | -74.1% | -138.5% |
| ROE | -82.2% | -36.7% | -90.6% | -168.6% | -71.5% | -105.8% |
| Shares Outstanding | 38M | 39M | 29M | 28M | 21M | 7M |
MYOMO, INC. passes 1 of 9 quality checks, indicating weak fundamentals.
The company's 5-year average gross margin is 69.2%.
MYOMO, INC. (MYO) has a 5-year average return on invested capital (ROIC) of -83.6%. This is below average and may indicate limited pricing power.
MYOMO, INC. (MYO) has a market capitalization of $28M. It is classified as a small-cap stock.
MYOMO, INC. (MYO) does not currently pay a regular dividend.
MYOMO, INC. (MYO) operates in the Orthopedic, Prosthetic & Surgical Appliances & Supplies industry, within the Healthcare sector.
MYOMO, INC. (MYO) reported annual revenue of $33 million in its most recent fiscal year, based on SEC EDGAR filings.
MYOMO, INC. (MYO) has a net profit margin of -19.0%. The company is currently unprofitable.
MYOMO, INC. (MYO) generated $-5 million in free cash flow in its most recent fiscal year. Negative free cash flow may indicate heavy investment or operational challenges.
MYOMO, INC. (MYO) has a debt-to-equity ratio of 0.02. This indicates a conservatively financed balance sheet.
MYOMO, INC. (MYO) reported earnings per share (EPS) of $-0.16 in its most recent fiscal year.
MYOMO, INC. (MYO) has a return on equity (ROE) of -36.7%. A negative ROE may indicate losses or negative equity.
MYOMO, INC. (MYO) has a 5-year average gross margin of 69.2%. This high margin suggests strong pricing power and a potential competitive moat.
The Ledger Terminal provides 9 years of financial data for MYOMO, INC. (MYO), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
MYOMO, INC. (MYO) has a book value per share of $0.64, based on its most recent annual SEC filing.